Form 4 · Filed May 4, 2026, 10:06 PM UTC
SPTX/Seaport Therapeutics, Inc.
Torres Denice — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 4, 2026 | C | other | 13,406 | — | — | 13,406 |
| May 4, 2026 | C | other | 42,105 | $0 | — | 0 |
| Apr 30, 2026 | A | other | 12,258 | $0 | — | 12,258 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-204468